Abstract
The aim of this research was to find the differentially expressed genes in the groups of patients with different stages of bladder cancer. Proper analysis could help to find biomarkers responsible for the occurrence of the most invasive forms of bladder cancer. The microarray data (series GSE31684) was used and the obtained genes were characterized and described. The data from 93 bladder cancer patients managed by radical cystectomy was used. The research also examined the impact of various parameters on survival after surgery. The results of the analysis showed that some genes can allow to diagnose various types of cancer grade and stage. The research also presented how smoking, lymph node metastases, cancer stage and grade can affect survival.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Atlas of Genetics and Cytogenetics in Oncology and Haematology. http://atlasgeneticsoncology.org/
Ackermann, A., Brieger, A.: The role of nonerythroid spectrin alpha II in cancer. J. Oncol. 2019, 1–14 (2019)
Benjamini, Y., Yekutieli, D.: The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 29(4), 1165–1188 (2001)
Bostrom, P.J., et al.: Staging and staging errors in bladder cancer. Eur. Urol. Suppl. 9, 2–9 (2010)
Cha, T.L.: Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Mol. Carcinog. 54(3), 167–177 (2015)
Chen, S., Zhang, N., Shao, J., Wang, T., Wang, X.: A novel gene signature combination improves the prediction of overall survival in urinary bladder cancer. J. Cancer 10, 5744–5753 (2019)
Chłosta, P.: Radykalne wycięcie pęcherza moczowego metodą laparoskopową - technika, wyniki i ograniczenia. Przegląd urologiczny 2(66), 24–28 (2011). (in Polish)
Di, Y., Chen, D., Yu, W., Yan, L.: Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis. Hereditas 156(1), 1–11 (2019)
Długosz, A., Królik, E.: Profilaktyka w raku pęcherza moczowego. Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2(4), 321–327 (2017). (in Polish)
Do, M.H., et al.: Targeting CD46 enhances anti-tumoral activity of adenovirus type 5 for bladder cancer. Int. J. Mol. Sci. 19, 2694 (2018)
Drewa, T.: Biologia raka naciekającego błonę mięśniową pęcherza moczowego. Przegląd urologiczny 2(66), 10–12 (2011). (in Polish)
Fondrevelle, M.E., et al.: The expression of twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urol. Oncol. Semin. Original Invest. 27(3), 268–276 (2009)
Foutadakis, S., Avgeris, M., Tokas, T., Stravodimos, K., Scorilas, A.: Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. Urol. Oncol. Semin. Original Invest. 32(1), 39.e29-39.e36 (2014)
Fröhlich, C., Albrechtsen, R., Dyrskjøt, L., Rudkjær, L., Ørntoft, T.F., Wewer, U.M.: Molecular profiling of ADAM12 in human bladder cancer. Clin. Cancer Res. 12(24), 7359–7368 (2006)
Gene Expression Omnibus: Series GSE31684. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31684
Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., Speed, T.P.: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4(2), 249–264 (2003)
Izdebska, M., Grzanka, A., Ostrowski, M.: Rak pęcherza moczowego - molekularne podłoże genezy i leczenia. Kosmos 54(2–3), 213–220 (2005). (in Polish)
Kaplan, E.L., Meier, P.: Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53(282), 457–481 (1958)
Liao, Z., Wang, X., Zeng, Y., Zou, Q.: Identification of dep domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues. Sci. Rep. 6(1), 1–11 (2016)
Liu, X., et al.: Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Tumor Biol. 37(6), 8367–8374 (2016). https://doi.org/10.1007/s13277-015-4703-5
Mares, J., Szakacsova, M., Soukup, V., Duskova, J., Horinek, A., Babjuk, M.: Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results. Neoplasma 60(3), 295–301 (2013)
Mattie, M., et al.: The discovery and preclinical development of ASG-5ME, an antibody–drug conjugate targeting SLC44A4-positive epithelial tumors including pancreatic and prostate cancer. Mol. Cancer Ther. 15(11), 2679–2687 (2016)
Mitra, A.P., Cote, R.J.: Molecular pathogenesis and diagnostics of bladder cancer. Annu. Rev. Pathol. 4(1), 251–285 (2009)
Neuzillet, Y., et al.: IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer. BMC Cancer 17(1), 1–12 (2017)
Oparina, N., et al.: Increase in NETO2 gene expression is a potential molecular genetic marker in renal and lung cancers. Russ. J. Genet. 48, 506–512 (2012). https://doi.org/10.1134/S1022795412050171
Poletajew, S.: Ocena stopnia zaawansowania raka pęcherza moczowego. Przegląd urologiczny 3(73), 22–26 (2012). (in Polish)
Purcell, J.W., et al.: LRRC15 is a novel mesenchymal protein and stromal target for antibody–drug conjugates. Cancer Res. 78(14), 4059–4072 (2018)
Riester, M., et al.: Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin. Cancer Res. 18(5), 1323–1333 (2012)
Shin, K., et al.: Hedgehog signaling restrains bladder cancer progression by eliciting stromal production of urothelial differentiation factors. Cancer Cell 26(4), 521–533 (2014)
Skrzypczyk, M., Grothuss, G., Dobruch, J., Chłosta, P.L., Borówka, A.: Rak pęcherza moczowego w Polsce. Bladder cancer in poland. Postępy Nauk Medycznych/Progress in Medicine 25(4), 311–319 (2012). (in Polish)
Song, Y.H., et al.: TWIST1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer. Urol. Oncol. Semin. Original Invest. 32(1), 31.e1-31.e7 (2014)
Szymańska, B., Długosz, A.: The role of the BLCA-4 nuclear matrix protein in bladder cancer. Adv. Hyg. Exp. Med./Postępy Higieny i Medycyny Doświadczalnej 71, 681–689 (2017)
Wilson, C.L., Miller, C.J.: Simpleaffy: a BioConductor package for affymetrix quality control and data analysis. Bioinformatics 21(18), 3683–3685 (2005)
Xiong, J.: Essential Bioinformatics. Cambridge University Press, New York (2006)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Tamulewicz, A., Mazur, A. (2022). Gene Expression Analysis of the Bladder Cancer Patients Managed by Radical Cystectomy. In: Pietka, E., Badura, P., Kawa, J., Wieclawek, W. (eds) Information Technology in Biomedicine. ITIB 2022. Advances in Intelligent Systems and Computing, vol 1429. Springer, Cham. https://doi.org/10.1007/978-3-031-09135-3_44
Download citation
DOI: https://doi.org/10.1007/978-3-031-09135-3_44
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-09134-6
Online ISBN: 978-3-031-09135-3
eBook Packages: Intelligent Technologies and RoboticsIntelligent Technologies and Robotics (R0)